<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-22857</identifier>
<setSpec>0304-4815</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Critical analysis of the article "Pharmacoeconomic analysis of methotrexate-resistant rheumatoid arthritis with combinations of leflunomide-methotrexate or infliximab-methotrexate"</dc:title>
<dc:creator>Ahumada, M. C</dc:creator>
<dc:creator>Fosbrook, L</dc:creator>
<dc:creator>Sender, M</dc:creator>
<dc:creator>Casado, M. A</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev. esp. reumatol. (Ed. impr.);30(4): 180-182, abr. 2003.</dc:source>
<dc:identifier>ibc-22857</dc:identifier>
<dc:title xml:lang="es">Análisis crítico del artículo "Análisis farmacoeconómico del tratamiento de la artritisreumatoide resistente ametotrexato con las combinaciones del eflunomida-metotrexato oinfliximab-metotrexato"</dc:title>
<dc:subject>^d28169^s22018</dc:subject>
<dc:subject>^d32355^s22018</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d32355^s22078</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d1178^s22057</dc:subject>
<dc:subject>^d28169^s22078</dc:subject>
<dc:subject>^d4419</dc:subject>
<dc:type>article</dc:type>
<dc:date>200304</dc:date>
</metadata>
</record>
</ibecs-document>
